Brain Tumor, Primary
Information
- Disease name
- Brain Tumor, Primary
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04831190 | Active, not recruiting | N/A | A Tailored Exercise Oncology Program for Neuro-Oncology Patients | April 15, 2021 | April 15, 2024 |
| NCT04365647 | Completed | Intra-operative Variation in Size of Brain Tumors After Craniotomy | March 1, 2018 | March 31, 2020 | |
| NCT00001574 | Completed | A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients With Primary and Metastatic Brain Tumors | March 14, 1997 | May 6, 2019 | |
| NCT02363933 | Completed | Phase 4 | Perampanel in Seizure Patients With Primary Glial Brain Tumors | April 7, 2015 | April 10, 2017 |
| NCT03262636 | Completed | Phase 1 | Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow) | June 2015 | March 10, 2020 |
| NCT03323450 | Completed | N/A | Cognitive Remediation Therapy for Brain Tumor Patients: Improving Working Memory | October 20, 2017 | June 1, 2020 |
| NCT03970499 | Completed | N/A | Ultrasound Elastography and Ultrasentive Doppler for Surgery of Brain Tumors | April 15, 2019 | April 15, 2023 |
| NCT02599142 | Completed | N/A | Comparing Immobilisation Shells in Cranial Radiotherapy | November 2015 | October 22, 2018 |
| NCT00241670 | Completed | Phase 3 | Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid | October 1999 | |
| NCT06106997 | Not yet recruiting | N/A | Clinical Feasibility of Brain Radiotherapy Using Synthetic CTs in an MRI-only Workflow | January 2024 | August 2025 |
| NCT06185686 | Not yet recruiting | Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brain Tumor Patients | June 30, 2024 | June 30, 2027 | |
| NCT06322342 | Recruiting | Phase 2 | Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent | March 15, 2024 | March 2025 |
| NCT03213002 | Recruiting | Phase 1/Phase 2 | Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM | June 13, 2017 | June 2026 |
| NCT04427384 | Recruiting | Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) | September 11, 2020 | December 31, 2028 | |
| NCT05254197 | Recruiting | SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON) | January 1, 2001 | December 31, 2035 | |
| NCT05480644 | Recruiting | Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors | December 1, 2022 | December 2032 | |
| NCT05775458 | Recruiting | Glutamate Excitotoxicity and Its Role in Glioblastoma Biology | June 1, 2020 | September 30, 2026 | |
| NCT05831631 | Recruiting | Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors | August 1, 2022 | August 1, 2025 | |
| NCT06057168 | Recruiting | Phase 3 | Performance of Elucirem® in DSC-MRI Perfusion of Brain Gliomas | September 7, 2023 | April 30, 2024 |
| NCT06282562 | Recruiting | N/A | FeelFit: High-intensity Interval Training to Improve Self-reported Physical Fitness in Brain Tumor Patients | March 2024 | August 15, 2026 |
| NCT04901806 | Terminated | Phase 1 | Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors | July 20, 2021 | July 26, 2023 |
| NCT02006407 | Terminated | N/A | A Pilot Study to Evaluate Neurocognitive Injury and Longitudinal Changes in White Matter During Radiation Therapy in Children With Primary Brain Tumors | June 2013 | December 2015 |
| NCT03373487 | Unknown status | N/A | Cognitive Rehabilitation in Brain Tumor Patients After Neurosurgery | July 1, 2015 | June 30, 2019 |
| NCT02113358 | Unknown status | N/A | Comparison of Stroke Volume Variation-guided Normovolemic and Restrictive Fluid Management During Craniotomy: a Randomized Controlled Trial | April 2014 | May 2015 |
| NCT05092802 | Unknown status | Phase 2 | The Efficacy of HLX208 (BRAF V600E Inhibitor) for Refractory Primary Brain Tumors With BRAF Mutation After First-line Treatment | December 23, 2021 | May 30, 2024 |
| NCT01445691 | Withdrawn | Phase 2 | More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery | November 2015 | September 2016 |
| NCT04776980 | Withdrawn | Early Phase 1 | Multimodality MRI and Liquid Biopsy in GBM | June 2022 | June 22, 2022 |